Skip to content
★ Sign in to follow
JM

Jyrki Mattila

Biospecifics Technologies CorpSocietal CDMO, Inc.Auxilium Pharmaceuticals Inc
Total declarations
21
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€7.1M

Latest filing published 24 May 2019 for BIOSPECIFICS TECHNOLOGIES CORP, €506k.

Filing timeline

BuySale
Jyrki Mattila

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

Jyrki Mattila: trading record in brief

Filings by Jyrki Mattila span 3 companies, the busiest being Auxilium Pharmaceuticals Inc, Biospecifics Technologies Corp and Societal CDMO, Inc. Over a trading history stretching from 28 June 2007 to 22 May 2019, the count stands at 21 filings.

Every open-market trade on record is a sale: 6 sales worth €7.1M. Besides market trades, the filings include 5 share grants and 10 option exercises. So far in 2019, the count stands at no purchases and 1 sale.

On 24 May 2019 came the latest disclosure, an option exercise for €506k in Biospecifics Technologies Corp. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Jyrki Mattila

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total

18 of 18 declarations